Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention

被引:439
作者
Pepin, Michel [1 ,2 ]
Bouloy, Michele [3 ]
Bird, Brian H. [4 ]
Kemp, Alan [5 ]
Paweska, Janusz [5 ]
机构
[1] AFSSA Site Lyon, F-69364 Lyon 7, France
[2] VetAgro Sup, F-69280 Marcy Letoile, France
[3] Inst Pasteur, Unite Genet Mol Bunyavirus, F-75724 Paris, France
[4] Ctr Dis Control & Prevent CDC, Special Pathogens Branch, Atlanta, GA 30333 USA
[5] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Special Pathogens Unit, ZA-2131 Sandrigham, South Africa
关键词
Rift Valley fever; molecular epidemiology; vector; pathogenesis; diagnostic; LINKED-IMMUNOSORBENT-ASSAY; MEDIATED ISOTHERMAL AMPLIFICATION; IMMUNOGLOBULIN-M ANTIBODIES; BORNE ENCEPHALITIS-VIRUS; HEMORRHAGIC-FEVER; EXPERIMENTAL-INFECTION; MESSENGER-RNA; NUCLEOCAPSID PROTEIN; RAPID DIAGNOSIS; CULEX-PIPIENS;
D O I
10.1051/vetres/2010033
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Rift Valley fever (RVF) virus is an arbovirus in the Bunyaviridae family that, from phylogenetic analysis, appears to have first emerged in the mid-19th century and was only identified at the begininning of the 1930s in the Rift Valley region of Kenya. Despite being an arbovirus with a relatively simple but temporally and geographically stable genome, this zoonotic virus has already demonstrated a real capacity for emerging in new territories, as exemplified by the outbreaks in Egypt (1977), Western Africa (1988) and the Arabian Peninsula (2000), or for re-emerging after long periods of silence as observed very recently in Kenya and South Africa. The presence of competent vectors in countries previously free of RVF, the high viral titres in viraemic animals and the global changes in climate, travel and trade all contribute to make this virus a threat that must not be neglected as the consequences of RVF are dramatic, both for human and animal health. In this review, we present the latest advances in RVF virus research. In spite of this renewed interest, aspects of the epidemiology of RVF virus are still not fully understood and safe, effective vaccines are still not freely available for protecting humans and livestock against the dramatic consequences of this virus.
引用
收藏
页数:40
相关论文
共 36 条
  • [21] Role of Culex and Anopheles mosquito species as potential vectors of rift valley fever virus in Sudan outbreak, 2007
    AlaaEddeen M Seufi
    Fatma H Galal
    BMC Infectious Diseases, 10
  • [22] Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR
    Nishiyama, Shoko
    Slack, Olga A. L.
    Lokugamage, Nandadeva
    Hill, Terence E.
    Juelich, Terry L.
    Zhang, Lihong
    Smith, Jennifer K.
    Perez, David
    Gong, Bin
    Freiberg, Alexander N.
    Ikegami, Tetsuro
    VIRULENCE, 2016, 7 (08) : 871 - 881
  • [23] Molecular detection of Rift Valley fever virus in serum samples from selected areas of Tanzania
    Augustino Alfred Chengula
    Christopher Jacob Kasanga
    Robinson Hammerthon Mdegela
    Raphael Sallu
    Mmeta Yongolo
    Tropical Animal Health and Production, 2014, 46 : 629 - 634
  • [24] Molecular detection of Rift Valley fever virus in serum samples from selected areas of Tanzania
    Chengula, Augustino Alfred
    Kasanga, Christopher Jacob
    Mdegela, Robinson Hammerthon
    Sallu, Raphael
    Yongolo, Mmeta
    TROPICAL ANIMAL HEALTH AND PRODUCTION, 2014, 46 (04) : 629 - 634
  • [25] Relative Distribution, Diversity, and Bloodmeal Sources of Mosquitoes and Known Vectors of Rift Valley Fever Phlebovirus in Three Differing Ecosystems in Bura, Tana River County, Kenya
    Mbotha, Deborah
    Hoppenheit, Antje
    Lindahl, Johanna
    Bett, Bernard
    Grace, Delia
    Lutomiah, Joel
    Pieper, Laura
    Kairu-Wanyoike, Salome
    Clausen, Peter-Henning
    VECTOR-BORNE AND ZOONOTIC DISEASES, 2020, 20 (05) : 365 - 373
  • [26] The molecular interplay of known phytochemicals as Culex pipiens and Rift Valley fever virus inhibitors through molecular docking
    Abutaha, Nael
    AL-Mekhlafi, Fahd A.
    Wadaan, Mohamed A.
    Rady, Ahmed Moustafa
    Baabbad, Almohannad A. A.
    Al-Khalifa, Mohammed S.
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2023, 30 (04)
  • [27] Paving the way for human vaccination against Rift Valley fever virus: A systematic literature review of RVFV epidemiology from 1999 to 2021
    Gerken, Keli N.
    LaBeaud, A. Desiree
    Mandi, Henshaw
    L'Azou Jackson, Maina
    Breugelmans, J. Gabrielle
    King, Charles H.
    PLOS NEGLECTED TROPICAL DISEASES, 2022, 16 (01):
  • [28] Inter-epidemic abundance and distribution of potential mosquito vectors for Rift Valley fever virus in Ngorongoro district, Tanzania
    Mweya, Clement N.
    Kimera, Sharadhuli I.
    Mellau, Lesakit S. B.
    Mboera, Leonard E. G.
    GLOBAL HEALTH ACTION, 2015, 8
  • [29] Identification of Potential Vectors and Detection of Rift Valley Fever Virus in Mosquitoes Collected Before and During the 2022 Outbreak in Rwanda
    Nsengimana, Isidore
    Hakizimana, Emmanuel
    Mupfasoni, Jackie
    Hakizimana, Jean Nepomuscene
    Chengula, Augustino A.
    Kasanga, Christopher J.
    Eastwood, Gillian
    PATHOGENS, 2025, 14 (01):
  • [30] An overview of chikungunya virus molecular biology, epidemiology, pathogenesis, treatment and prevention strategies
    Javaid, Anam
    Ijaz, Aroosa
    Ashfaq, Usman Ali
    Arshad, Maham
    Irshad, Shakeel
    Saif, Saira
    FUTURE VIROLOGY, 2022, 17 (08) : 593 - 606